Welcome to our dedicated page for MindWalk Holdings SEC filings (Ticker: HYFT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MindWalk Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MindWalk Holdings's regulatory disclosures and financial reporting.
MindWalk Holdings Corp. (HYFT) entered a Sales Agreement enabling an at‑the‑market offering of up to $30 million in common shares. The company may offer and sell shares from time to time through JonesTrading Institutional Services LLC as sales agent, under its effective Form F‑3 shelf, as supplemented by a prospectus dated November 7, 2025.
Shares may be sold on The Nasdaq Capital Market or other existing trading markets using methods permitted by law and deemed an “at the market offering” under Rule 415(a)(4). The company is not obligated to sell any shares. JonesTrading’s compensation is 3.0% of the gross proceeds of any shares sold. The agreement may be terminated by either party as provided in the contract.
MindWalk Holdings Corp. (HYFT) launched an at-the-market offering of up to U.S.$30,000,000 in common shares through JonesTrading as sales agent. Sales may be made on Nasdaq under Rule 415(a)(4). JonesTrading will earn a 3.0% commission, and there is no escrow. The shares will not be sold in Canada. HYFT last closed at U.S.$1.76 on November 4, 2025.
MindWalk expects to use any net proceeds for research and development, capital expenditures (including laboratory expansion), working capital and general corporate purposes, and it may allocate a portion to repurchase securities or pursue complementary investments or acquisitions. Common shares outstanding were 46,157,312 as of July 31, 2025.
MindWalk Holdings Corp. furnished a Form 6-K that includes Exhibit 99.1, a Revised Statement of Executive Compensation dated November 6, 2025.
The company states that Exhibit 99.1 is incorporated by reference into its existing registration statements on Form S-8 and Form F-3. The report was signed by Chief Executive Officer Jennifer Bath.
MindWalk Holdings Corp. filed a Form S-8 registering 5,620,254 common shares issuable under the ImmunoPrecise Antibodies Ltd. 2025 Stock Incentive Plan. The shares may be issued through equity awards, including options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, or other stock-based awards.
The company is a non-accelerated filer and an emerging growth company. Standard indemnification provisions for directors and officers under the British Columbia Business Corporations Act and the company’s articles are described, along with related insurance coverage.
FAQ
What is the current stock price of MindWalk Holdings (HYFT)?
What is the market cap of MindWalk Holdings (HYFT)?
